← Leaderboards
James Paul O'Malley
University Of Wisconsin Madison
$222,307
Attributed
$222,307
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $146.2K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$222,307 · 3
By mechanism
R43$146,237 · 1
P51$76,070 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Agonist”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Alan G. Barbour · University Of California Irvine$40,092,035
- Alexandros Makriyannis · University Of Connecticut Storrs$29,942,402
- Scott T Weiss · University Of California, San Diego$28,624,344
- John Didsbury · T3d Therapeutics, Inc.$25,150,614
Research focus
AgonistAlveolar BoneAlveolar RidgeAnimal ColonyApplications GrantsAreaBaseBiological PreservationBoneBone DensityBone LossBone Marrow CellsBone RegenerationBone ResorptionBusinessesCalvariaCanis FamiliarisCell ModelCellsCharacteristicsCollagenCostCraniofacialAging
Grant awards (4)
An EP4 receptor agonist for enhancing alveolar bone regeneration in tooth-extract$146,237
R43 · FY2010 · DE · contact PI
AGE-RELATED DECLINE IN TESTOSTERONE BIOACTIVITY$27,215
P51 · FY2006 · RR · contact PI
AGE-RELATED DECLINE IN TESTOSTERONE BIOACTIVITY$34,795
P51 · FY2005 · RR
AGE-RELATED DECLINE IN TESTOSTERONE BIOACTIVITY$14,060
P51 · FY2004 · RR